✦ LIBER ✦

Clinically relevant therapeutic endpoints in type I Gaucher disease

✍ Scribed by C. E. M. Hollak; M. Maas; J. M. Aerts

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Possible therapeutic effects of myxobact

✍ Sung-Jo Kim; Sunyang Kang; June-Bum Kim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 479 KB

121. Immune thrombocytopenia in Type I G

✍ Hanna Rosenbaum; Tina Napso; Lilach Bonstein 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Sustained therapeutic effects of oral mi

✍ D. Elstein; C. Hollak; J. M. F. G. Aerts; S. van Weely; M. Maas; T. M. Cox; R. H 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 238 KB

Vertebral fractures in Gaucher disease t

✍ R.-M. Javier; E. Hachulla; C. Rose; V. Gressin; P. Chérin; E. Noël; C. de Roux-S 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 132 KB

Protein, glucose and energy metabolism i

✍ O. A. F. Bodamer; A. Vellodi 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 32 KB

Long-term clinical outcomes in type 1 Ga

✍ Weinreb, Neal J.; Goldblatt, Jack; Villalobos, Jacobo; Charrow, Joel; Cole, J. A 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 210 KB